InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: Empiricst1 post# 238258

Thursday, 08/23/2018 8:28:48 PM

Thursday, August 23, 2018 8:28:48 PM

Post# of 403062
Empiricst1,

¨It takes a while and as noted, we are not talking about a huge staff. Doing the statistical analyses is easy, mostly automate after it has been entered (in itself not so easy), the rest is not.¨

Apparently it takes much longer than LE advised we loyal investors´ of ctix/ipix. Regarding p2b, they´ve gone from 3q17 to 4q17 to 1q18 to 1st half 18, to 9/30/18. Anyone who´s not a wee bit taken aback and upset is dishonest imo. It implies he doesn´t know what he´s talking about, while his words have killed most investors.

Regarding another ipix venture, oral mucositis, Galera Therapeutics blows ipix out of the water when it comes to execution.

Ph2b OM study:

Galera started 14 months later than ipix and finished 2 months ahead of ipix(ipix was 69% longer)

Galera enrolled 265% more patients than ipix(223 vs 61)

Galera used 281% more sites than ipix(61 vs 16)

Galera received BTD 164 days after primary trial completion vs ipix, 249 days and counting.

To be noted as why results may have taken longer for ipix OM results- ipix had 2 primary outcome mesures vs 1 by Galera, ipix had 16 secondary outcome measures vs 7 for Galera, Ipix had zero other outcome measures vs 14 for Galera. I won´t attempt to filter them.

kfc

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News